Latest California Healthline Stories
Top Research Centers Call Trump’s Proposed NIH Cuts ‘Shocking’
Research institutions that stand to lose the most include UCSF, Stanford University and UC San Diego. Total NIH funding for the University of California system reached nearly $2 billion in fiscal year 2016.
Cholesterol Drug Prevents Heart Attacks — But It Doesn’t Come Cheap
A cholesterol-lowering drug called Repatha cuts the risk of heart attacks, strokes and heart-related death by 20 percent, according to a new study.
$89,000 Orphan Drug Gets A New Owner — And Likely A New Price
Marathon, maker of an expensive treatment for Duchenne muscular dystrophy, sells the drug for $140 million in cash and stock to PTC Therapeutics.
Experimental Stem Cell Treatment Leaves Three Women Blind
Researchers, who detail the women’s experiences in the New England Journal of Medicine, say it exposes the need for better regulation of clinical trials.
Where You Live May Determine How You Die. Oregon Leads The Way.
A state with integrated systems for end-of-life care offers better treatment for the seriously ill, according to a new study.
Companies Behind Health Savings Accounts Could Bank On Big Profits Under GOP Plan
With Republicans in control of Congress and the White House, HSAs — a longtime favorite of conservatives — are likely to get a boost.
To Save On Drug Costs, Insurer Wants To Steer You To ‘Preferred’ Pharmacies
Blue Shield of California is hoping to steer consumers to “preferred” pharmacies where drugs are cheaper and copays lower.
Trump, Dems Look For Common Ground On Drug Prices
Two Democratic congressmen met with President Trump to seek his support for a bill to expand the government’s ability to negotiate drug prices, but it’s not clear it would have much impact or will gain support.
House GOP Health Bill Jettisons Insurance Mandate, Much Of Medicaid Expansion
After intense negotiations among party’s factions, leaders unveil legislation that committees will mark up this week.
Are Virtual Doctor Visits Really Cost-Effective? Not So Much, Study Says
Rand Corp. finds that telehealth encourages patients to seek care for minor illnesses they wouldn’t bother to make an office visit for, raising overall health costs.